The news that Ocrelizumab appears to be in line to be the first drug to be approved to treat PPMS and there is very little chatter on this board, anywhere! Wow, am I surprised. I expected every PPMSer, here, to contribute in some way, but have read very little. What goes?
Announcement
Collapse
No announcement yet.
Is anyone paying attention ?
Collapse
X
-
People are waiting
Originally posted by JerryD View PostThe news that Ocrelizumab appears to be in line to be the first drug to be approved to treat PPMS and there is very little chatter on this board, anywhere! Wow, am I surprised. I expected every PPMSer, here, to contribute in some way, but have read very little. What goes?
I've been singing the praises of LDN and healthy diet because they're working for me, and I'm sure others will sing about Ocrelizumab if it works for them.
I'm more likely to believe anecdotal evidence from sufferers than data from big pharmacy.
Check out "info on Naltrexone" on the "treatment..." thread and let me know what you think. Rand
-
Rand, I was on LDN 4.5 mgs for about 3 years. My current MS 'specialist' saw a problem with my blood levels and suggested that I discontinue it. I am following his counsel. I hope he is right. I read everything on the web about LDN before I started on it. Since then, much more info has been added. Thanks for responding. Good luck
Comment
-
I am paying attention, however it is always been my thinking that MS is a great place for pharmacists to try out drugs.
Since with MS there will always be remitting/relapsing they can always claim their drug was responsible for it.
Sound like a pessimist? I guess I am, but until I see a real cure, I won't be taking any drugs..
Comment
-
JerryD
I was excited about Ocrelizumab (for a minute) until I researched it.
In one of the articles, it said that the drug was originally supposed to be a blockbuster treatment for rheumatoid arthritis and lupus. But in early 2010, treatment was suspended for RA and Lupus due to serious and opportunistic infections, several of which were fatal.
The article went on to say that Ocrelizumab may remain a viable candidate for MS, however, given that serious infection is an acceptable risk in the MS population.
Another article stated that researchers didn't close the curtain entirely on Ocrelizumab, as they continued a trial for MS, where the appetite for risk is distinctly larger.
On the other hand, maybe it's safer now? You never know.PPMS for 26 years (dx 1998)
~ Worrying will not take away tomorrow's troubles ~ But it will take away today's peace. ~
Comment
-
Originally posted by JerryD View PostI read something about serious infections and fatalities. It may be that some think this is acceptable but I am not going to believe anything until the FDA approval next year. Hope springs eternal !PPMS for 26 years (dx 1998)
~ Worrying will not take away tomorrow's troubles ~ But it will take away today's peace. ~
Comment
Comment